USD10
RNAC Shares
About Cartesian TherapeuticsCartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
USD10
RNAC Shares
About Cartesian TherapeuticsCartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$171.59M
OPEN PRICE
$6.52
LOW (1Y)
$5.60
HIGH (1Y)
$15.57
LOW (24H)
$5.77
HIGH (24H)
$6.71
VOLUME (24H)
$278.81K
218.53%
Price history
Time | Price | Change |
|---|---|---|
Today | $6.52 | |
1 Day | $5.84 | 0.00% |
1 Week | $7.46 | |
1 Month | $7.99 | |
1 Year | $10.85 |
Past performance is not a reliable indicator of future results.
Discover more
Popular prediction markets
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.
